On Oct. 28, 2021, Corlears School partnered with LREI School, Village Community School, and City and Country School to host Downtown Independent Schools Present: Expert Advice on COVID-19 Vaccines for Young Children.
The event brought together a panel of experts to help families understand and prepare for the FDA authorization of COVID-19 vaccinations for children ages 5 to 11.
The exceptional lineup of panelists included:
-
Dr. David Boguslavsky, CEO of Back to Work Solutions
-
Dr. Keith Gottlieb, PhD, Virologist, Clinical Immunology
-
Dr. Dyan Hes, Founder of Gramercy Pediatrics
-
Dr. Czer Anthoney Lim, Pediatrician, Emergency Medicine, Mt. Sinai Hospital
-
Julie Kornfeld, PhD, MPH, Vice Provost and Associate Professor of Epidemiology, Columbia University's Mailman School of Public Health
The event was moderated by Corlears’ Alex Gelman, Director of Educational Program Operations and Pandemic Response Coordinator at Corlears.
The discussion covered three main topics, including the science behind the COVID-19 vaccine and the approval process, the risks and benefits of the vaccine in children ages 5 to 11, and whether each panelist would vaccinate their own child against COVID-19.
Dr. C. Anthoney Lim spoke first-hand about the process for Pfizer’s pediatric trial, as his 7-year-old son was a trial participant. Dr. Lim shared the data reports his family had to provide, testing performed on participants, and his confidence in the trial.
“This is probably one of the best studied therapies ever [...],” said Dr. Lim when discussing concerns over the timeline of the trial.
The conversation then moved to key safety data, potential risks of myocarditis to both vaccinated and unvaccinated children, and whether there are any long-term impacts of mRNA vaccines in children.
At the end of the evening, panelists shared recommendations on how families should make the decision as to whether to get their children vaccinated against COVID-19 or not.
Corlears is proud to have hosted this informative and important discussion.
If you were not able to make it to this event, make sure to watch the expert panel discussion here.
